News Paige's cancer detection AI gets FDA breakthrough status Paige has been awarded breakthrough device status from the FDA for an AI tool that can be used to detect cancer across different areas of the body.
News FDA clears AI-powered prostate cancer detection software Software that can help pathologists detect prostate cancer from slides of biopsies more effectively has been approved by the FDA.
News Start-up Paige.AI bullish about ‘computational pathology’ re... A new digital health start up Paige.AI has been launched this week, promising to revolutionise clinical diagnosis and cancer treatment through use of artificial intelligence (AI).
News FDA clears Nuvation's first product Ibtrozi, for lung cancer Nuvation is set to launch its first commercial product after the FDA approved its ROS1 inhibitor Ibtrozi as a treatment for ROS1-positive lung cancer.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face